Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This is a research study of ribavirin which will be given in combination with vismodegib
and/or decitabine. The purpose of this study is to see if patients respond to treatment when
ribavirin is given with vismodegib alone or in combination with decitabine.